高级搜索

胃癌患病风险基因研究进展

李 龙, 李 静, 郑燕芳, 张积仁

李 龙, 李 静, 郑燕芳, 张积仁. 胃癌患病风险基因研究进展[J]. 肿瘤防治研究, 2014, 41(05): 492-495. DOI: 10.3971/j.issn.1000-8578.2014.05.034
引用本文: 李 龙, 李 静, 郑燕芳, 张积仁. 胃癌患病风险基因研究进展[J]. 肿瘤防治研究, 2014, 41(05): 492-495. DOI: 10.3971/j.issn.1000-8578.2014.05.034
Review on Genetic Susceptibility to Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 492-495. DOI: 10.3971/j.issn.1000-8578.2014.05.034
Citation: Review on Genetic Susceptibility to Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 492-495. DOI: 10.3971/j.issn.1000-8578.2014.05.034

胃癌患病风险基因研究进展

详细信息
    作者简介:

    李龙(1988-),男,博士在读,主要从事消化道肿瘤的防治与基础研究

    通信作者:

    郑燕芳,E-mail: zyfcn@yahoo.com

  • 中图分类号: R735.2

Review on Genetic Susceptibility to Gastric Cancer

  • 摘要: 胃癌是我国常见的恶性肿瘤,其致病因素涉及环境及遗传等多种因素的相互作用。本文对胃癌患病风险有关的代谢酶相关基因、解毒酶基因、免疫相关基因、DNA修复基因、原癌基因及抑癌基因的研究进展作一综述。

     

    Abstract: Both morbidity and mortality of gastric cancer are very high in China. The interaction of environment factors and genetic mutation plays an important role in the pathogenesis of gastric cancer. This paper is a review on genes related to gastric cancer such as metabolic enzyme genes, detoxifi cation enzyme genes, immune related genes, DNA repair genes, oncogenes and tumor suppressor genes.

     

  • [1] Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice[J]. Lancet Oncol,2008,9(3):279-87.
    [2] De Re V, Cannizzaro R, Canzonieri V, et al. MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer[J]. Tumour Biol,2010,31(1):23-32.
    [3] Dong X, Wu J, Liang P, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a metaanalysis[ J] Arch Med Res,2010,41(2):125-33.
    [4] Yim DJ, Kim OJ, An HJ, et al. Polymorphisms of thymidylate synthase gene 5’- and 3’-untranslated region and risk of gastric cancer in Koreans[J]. Anticancer Res,2010,30(6):2325-30.
    [5] Zhou JY, Shi R, Yu HL, et al. The association between two polymorphisms in the TS gene and risk of cancer: a systematic review and pooled analysis[J]. Int J Cancer,2012,131(9):2103-16.
    [6] Yoo JY, Kim SY, Hwang JA, et al. Association study between folate pathway gene single nucleotide polymorphisms and gastric cancer in Koreans[J]. Genomics Inform,2012,10(3):184-93.
    [7] Zhuo W, Zhang L, Wang Y, et al. CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 casecontrol studies[J]. PLoS One,2012,7(11):e48265.
    [8] Luo YP, Chen HC, Khan MA, et al. Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility[J]. Tumour Biol,2011,32(1):215-22.
    [9] Zhang Y, Sun LP, Xing CZ, et al. Interaction between GSTP1 Val allele and H. pylori infection, smoking and alcohol consumption and risk of gastric cancer among the Chinese population[J]. PLoS One,2012,7(10):e47178.
    [10] Peng B, Cao L, Ma X, et al. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk[J]. Mutagenesis,2010,25(4):371-9.
    [11] Lin XD, Chen G, Li C, et al. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer][J]. Zhonghua Yu Fang Yi Xue Za Zhi,2011,45(8):711-6.[林 贤东,陈刚,力超,等.基质金属蛋白-2和基质金属蛋白2组织抑 制剂基因多态性与胃癌遗传易感相关性[J].中国预防医学杂 志,2011,45(8):711-6.]
    [12] Dey S, Stalin S, Gupta A, et al. Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population[J]. Mol Carcinog,2012,51 Suppl 1:E42-53.
    [13] Kim JH, Pyun JA, Lee KJ, et al. Study on association between single nucleotide polymorphisms of MMP7, MMP8, MMP9 genes and development of gastric cancer and lymph node metastasis[J]. Korean J Gastroenterol,2011,58(5):245-51.
    [14] Lee TY, Yu CC, Wu CC, et al. MMP-9 -1562 promoter polymorphism associated with gastric cancer risk in females[J]. Hepatogastroenterology,2013,60(126),[Epub adhead of print].
    [15] Liang J, Li Y, Liu X, et al. Relationship between cytokine levels and clinical classifi cation of gastric cancer[J]. Asian Pac J Cancer Prev,2011,12(7):1803-6.
    [16] El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer[J]. Nature,2000,404(6776):398-402.
    [17] Xue H, Lin B, Ni P, et al. Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis[J]. J Gastroenterol Hepatol,2010,25(10):1604-17.
    [18] Chiurillo MA, Moran YH, Cañas M, et al. Infection with specifi c Helicobacter pylori-cag pathogenicity island strains is associated with interleukin-1B gene polymorphisms in Venezuelan chronic gastritis patients[J]. Dig Dis Sci,2011,56(2):449-56.
    [19] Li K, Yang J, Chen ZR. Relationships among interleukin-1beta, interleukin-1 receptor antagonist gene polymorphism and susceptibility to gastric cancer[J]. Sichuan Da Xue Xue Bao Yi Xue Ban,2010,41(6):1039-43.[李卡,杨婕,陈增蓉.IL-1β和IL-1受 体拮抗剂基因多态性与胃癌遗传易感性的相关性研究[J].四川 大学学报(医学版),2010,41(6):1039-43.]
    [20] Burada F, Angelescu C, Mitrut P, et al. Interleukin-4 receptor -3223T→C polymorphism is associated with increased gastric adenocarcinoma risk[J]. Can J Gastroenterol,2012,26(8): 53 2-6.
    [21] Sugimoto M, Yamaoka Y, Furuta T. Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer[J]. World J Gastroenterol,2010,16(10):1188-200.
    [22] Yin YW, Sun QQ, Hu AM, et al. Associations between interleukin-6 gene -174 C/G and -572 C/G polymorphisms and the risk of gastric cancer: a meta-analysis[J]. J Surg Oncol,2012,106 (8) :987-93.
    [23] Shimura T, Suehiro T, Suzuki H, et al. Peptides derived from a soluble molecule of the human leukocyte antigen (HLA) class I cause apoptosis in gastric cancer cell lines[J]. Dig Dis Sci,2009,54(1):63-9.
    [24] Ando T, Ishikawa T, Kato H, et al. Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection[J]. Int J Cancer,2009,125(11):2595-602.
    [25] Huang LM, Cheng Y, Yu DK, et al. Association between HLA-DQA1 gene copy number polymorphisms and susceptibility to gastric cancer[J]. Zhonghua Zhong Liu Za Zhi,2012,34(4):269-71.[黄理明,程炎,于典科,等.HLA-DQA1 基因拷贝数多态与胃癌发病风险的关系[ J ] .中华肿瘤杂 志,2012,34(4):269-71.]
    [26] Zhao Y, Wang J, Tanaka T, et al. Association between HLADQ genotypes and haplotypes vs Helicobacter pylori infection in an Indonesian population[J]. Asian Pac J Cancer Prev,2012,13(4):1247-51.
    [27] Hold GL, Rabkin CS, Gammon MD, et al. CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations[J]. Eur J Cancer Prev,2009,18(2):117-9.
    [28] Tahara T, Shibata T, Hirata I, et al. CD14 promoter-159 polymorphism is associated with reduced risk of intestinaltype gastric cancer in a Japanese population[J]. Dig Dis Sci,2009,54(7):1508-12.
    [29] Yang JJ, Ko KP, Cho LY, et al. The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study[J]. BMC Cancer,2009,9:238.
    [30] Tahara T, Shibata T, Yamashita H, et al. Synergistic effect of IL- 1& beta; and TNF-α polymorphisms on the H. pylori-related gastric premalignant condition[J]. Hepatogastroenterology,2012,59(120): 24 16-20.
    [31] Dong Z, Guo W, Zhou R, et al. Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China[J]. J Clin Gastroenterol,2008,42(8):910-5.
    [32] Zhang CZ, Chen ZP, Xu CQ, et al. Correlation of XPD gene with susceptibility to gastric cancer[J]. Ai Zheng,2009,28(11):1163-7.
    [33] Chen Z, Zhang C, Xu C, et al. Effects of selected genetic polymorphisms in xeroderma pigmentosum complementary group D on gastric cancer[J]. Mol Biol Rep,2011,38(3):1507-13.
    [34] Corso G, Marrelli D, Pedrazzani C, et al. Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1)[J]. J Gastrointest Surg,2009,13(12):2233-8.
    [35] Yan L, Yanan D, Donglan S, et al. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma[J]. Dis Esophagus,2009, 22 (5):396-401.
    [36] Chen B, Zhou Y, Yang P, et al. Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis[J]. Mol Biol Rep,2012,39(2):1305-13.
    [37] Fang F, Wang J, Yao L, et al. Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis[J]. Med Oncol,2011,28(4):999-1003.
    [38] Capelle LG, Van Grieken NC, Lingsma HF, et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands[J]. Gastroenterology,2010,138(2):487- 92.
    [39] Wu J, Wang D, Song L, et al. A new familial gastric cancerrelated gene polymorphism: T1151A in the mismatch repair gene hMLH1[J]. Mol Biol Rep,2011,38(5):3181-7.
    [40] Al-Moundhri MS, Al-Khanbashi M, Al-Kindi M, et al. Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk[J]. World J Gastroenterol,2010,16(27):3432-6.
    [41] Corso G, Berardi A, Marrelli D, et al. CDH1 C-160A promoter polymorphism and gastric cancer risk[J]. Eur J Cancer Prev,2009,18(1):46-9.
    [42] Jakubowska A, Lawniczak M, Wojnarska B, et al. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland[J]. Fam Cancer,2010,9(4):605-8.
    [43] Bellini MF, Cadamuro AC, Succi M, et al. Alterations of the TP53 gene in gastric and esophageal carcinogenesis[J]. J Biomed Biotec hnol,2012,2012:891961.
    [44] Cañas M, Morán Y, Camargo ME, et al. TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela[J]. Invest Clin,2009,50(2):153-61.
    [45] Liu L, Wang K, Zhu ZM, et al. Associations between P53 Arg72Pro and development of digestive tract cancers: a metaanalysis[ J] Arch Med Res,2011,42(1):60-9.
  • 期刊类型引用(5)

    1. 于小梅,李晶晶,贾波. 输液港导管形成纤维蛋白鞘的不良影响及干预措施的研究进展. 当代护士(下旬刊). 2025(04): 25-29 . 百度学术
    2. 孙涛,罗和国. 超声引导下腋静脉穿刺置管的研究进展. 国际麻醉学与复苏杂志. 2025(04): 414-418 . 百度学术
    3. 金光鑫,张芳琴,王雅雯,郭艳,仇晓霞,张学彬. 超声联合DSA引导下经上臂静脉输液港植入术在恶性肿瘤化疗患者中的临床应用研究. 介入放射学杂志. 2024(07): 733-737 . 百度学术
    4. 程巧琳,陈金华,施晓琳,闵伟. 肌骨超声在恶性肿瘤患者行静脉输液港植入术及术后监测中的应用. 海南医学. 2024(15): 2210-2213 . 百度学术
    5. 田竹. 不同导管尖端定位法在静脉输液港置入中的应用研究. 循证护理. 2024(17): 3104-3108 . 百度学术

    其他类型引用(1)

计量
  • 文章访问数:  1391
  • HTML全文浏览量:  426
  • PDF下载量:  1385
  • 被引次数: 6
出版历程
  • 收稿日期:  2013-03-27
  • 修回日期:  2013-09-09
  • 刊出日期:  2014-05-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭